Supplemental Table 1

Published: 26 August 2026| Version 1 | DOI: 10.17632/3yg9g9kcrx.1
Contributors:
,
, Rebecca Quiñonez, Jaina Gaudette, Mohsen Mokhtari, Redina Bardhi, Mavra Masood, Lydiah Mpyisi, Jasira Ziglar, Joseph Fakhoury,

Description

Overview of FDA regulatory pathways, device classifications, and practical interpretations of claims for representative red and near-infrared photobiomodulation (PBM) devices.

Files

Institutions

Categories

Photobiology, Photomedicine

Licence